Recent Updates
Recently added Catalysts
AMGN

Amgen to Present at the Baird Growth Stock Conference Amgen (NASDAQ:AMGN) will present at the Baird Growth Stock conference on Wednesday, May 9, 2012, at the Four Seasons Hotel, Chicago, Ill., beginning...

Key Takeaway: THOUSAND OAKS, Calif. , May 4, 2012 /PRNewswire/ -- Amgen (NASDAQ: AMGN ) will present at the Baird Growth Stock conference on Wednesday, May 9, 2012 , at the Four Seasons Hotel, Chicago, Ill. , beginning at 8:20 a.m. Central Daylight Time . Arvind Sood , vice president of Invest

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+30%
120-day peak, hindsight
Typical move
1.4%
average across 15 past catalysts
Lead asset
Maridebart cafraglutide
Phase 3 · Heart Failure With Preserved Ejection Fraction

Full Press Release Details

THOUSAND OAKS, Calif. , May 4, 2012 /PRNewswire/ -- Amgen (NASDAQ: AMGN ) will present at the Baird Growth Stock conference on Wednesday, May 9, 2012 , at the Four Seasons Hotel, Chicago, Ill. , beginning at 8:20 a.m. Central Daylight Time . Arvind Sood , vice president of Investor Relations at Amgen, will present. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com , under Investors.
CONTACT: Amgen, Thousand Oaks Christine Regan , 805-447-5476 (media) Eric Hyllengren , 805-447-1060 (investors)
Last updated: May 4, 2012